Table 3.
Maternal adverse events*
| Adverse event | Retosiban n = 30 n (%) | Placebo n = 34 n (%) |
|---|---|---|
| Headache | 4 (13) | 1 (3) |
| Dyspepsia | 3 (10) | 1 (3) |
| Back pain | 2 (7) | 0 |
| Nausea | 2 (7) | 1 (3) |
| Abdominal pain, upper | 1 (3) | 1 (3) |
| Amniotic fluid, decreased | 1 (3) | 1 (3) |
| Constipation | 1 (3) | 1 (3) |
| Premature rupture of membranes | 1 (3) | 2 (6) |
| Paraesthesia | 0 | 2 (6) |
| Polyhydramnios | 0 | 2 (6) |
| Post-partum depression | 0 | 2 (6) |
Listed are all adverse events, regardless of treatment group. Women with more than one occurrence of the same type of adverse event are listed only once.